Antiretroviral treatment adherence and associated factors among people living with HIV in developing country, Myanmar
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20161405Keywords:
Treatment for HIV/AIDS, Antiretroviral therapy adherence, MyanmarAbstract
Background: The provision of antiretroviral therapy (ART) has been started in Myanmar, since 2005 by both public and private sectors. Adherence is one of the major critical issues in the clinical management of HIV-infected patients receiving ART. This study aims to determine the level of adherence to ART and possible associated factors in public ART centers, Yangon Region, Myanmar.
Methods: MT his cross-sectional analytical study was conducted between May to July 2015. A total of 425 people living with HIV (PLHIV) were interviewed with pretested structured questionnaires. The multi-method tools were used to access the level of ART adherence. The generalized estimating equation (GEE) model and multiple logistic regression models were administered to determine the possible associated factors to ART adherence.
Results: Only 76.24% (95% CI=72.17-80.29) of the respondents had optimal ART adherence (≥95%). The respondents of aged more than 40 years were unlikely to adhere ART when compared with younger age (AOR=0.01, 95% CI=0.003-0.05). Those patients who had not satisfied with ART provider services (AOR=0.04, 95% CI=0.02-0.12) were also significantly less likely adhering to ART. However, non-smokers and being taking regular exercise were found to be more likely to adhere to ART.
Conclusion: About a quarter of the PLHIV had suboptimal ART adherence. The older age group and poor patient-provider relationship were found to be the barrier to ART adherence.
References
Volberding PA, Deeks SG. Antiretroviral therapy and management of HIV infection. The Lancet. 2010;376(9734):49-62.
Wang H, Zhou J, He G, Luo Y, Li X, Yang A. Consistent ART adherence is associated with improved quality of Life, CD4 counts, and reduced hospital costs in central China. AIDS Research and Human Retroviruses. 2009;25(8):757-63.
Amberbir A, Woldemichael K, Getachew S, Girma B, Deribe K. Predictors of adherence to antiretroviral therapy among HIV-infected persons: a prospective study in Southwest Ethiopia. BMC Pub Health. 2008;8:265.
Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. New England J Med. 1998;338(13):853-60.
Rathbun RC, Lockhart SM, Stephens JR. Current HIV treatment guidelines: an overview. Current Pharmaceutical Design. 2006;12(9):1045-63.
Mannheimer SB, Matts J, Telzak E, Chesney M, Child C, Wu AW, et al. Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence. AIDS Care. 2005;17(1):10-22.
M D, As F, Jg B, Je K, Ak P. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV. MMWR Recommendations and Reports: Morbidity and Mortality Weekly Report. Recommendations and Reports/Center of Disease Control. 2002;51(RR-7):1-55.
Phillips JC. Antiretroviral therapy adherence: testing a social context model among Black men who use illicit drugs. J Assoc Nurs AIDS Care. 2011;22(2):100-27.
Catz SL, Kelly JA, Bogart LM, Benotsch EG, McAuliffe TL. Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychology: official journal of the division of health psychology. American Psychological Association. 2000;19(2):124-33.
Protopopescu C, Raffi F, Roux P, Reynes J, Dellamonica P, Spire B et al. Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data. J Antimicrob Chemother. 2009;64(3):599-606.
Miller CM, Ketlhapile M, Rybasack-Smith H, Rosen S. Why are antiretroviral treatment patients lost to follow-up? A qualitative study from South Africa. Trop Med Intern Health. 2010;15(s1):48-54.
Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annal of Intern Med. 2000;133(1):21-30.
Laurence J, ed. Medication Adherence in HIV/AIDS. 1 edition. Larchmont, NY: Mary Ann Liebert Inc; 2004:396.
MOH. Health in Myanmar 2015. 2015. Available at http://www.moh.gov.mm/. Accessed on 20 March 2016.
New TW. Antiretroviral therapy adherence among people living with HIV/AIDS in public and INGO centers, Yangon. 2013.
Thar K. Study of AIDS patients treated with Antiretroviral Therapy in Wai-Bargi Specialist Hospital, Yangon. 2005.
Hsieh FY, Bloch DA, Larsen MD. A simple method of sample size calculation for linear and logistic regression. Statistics in Medicine. 1998;17(14):1623-34.
Steel G, Nwokike JP, Joshi M. Development of a multi method tool to measure art adherence in resource-constrained settings: the South Africa Experience. USAID. 2007;61.
Sujipittham. Factors affecting adherence to ART regimens among HIV-infected/AIDS-patients at Taksin Hospital. 2012.
Rai S, Mahapatra B, Sircar S, Raj PY, Venkatesh S, Shaukat M, et al. Adherence to Antiretroviral Therapy and Its Effect on Survival of HIV-Infected Individuals in Jharkhand, India. Plos One. 2013;8(6):e66860.
Kumar A, Alandikar V, Mhaskar R, Emmanuel P, Djulbegovic B, Patel S, et al. Adherence to antiretroviral therapy in India: a systematic review and meta-analysis. Indian J of Community Med. 2013;38(2):74.
Mills EJ, Nachega JB, Buchan I, Orbinski J, Attaran A, Singh S, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA. 2006;296(6):679-90.
Uzochukwu BSC, Onwujekwe OE, Onoka AC, Okoli C, Uguru NP, Chukwuogo OI. Determinants of non-adherence to subsidized anti-retroviral treatment in southeast Nigeria. Health Policy and Planning. 2009;24(3):189-96.
Rougemont M, Stoll BE, Elia N, Ngang P. Antiretroviral treatment adherence and its determinants in Sub-Saharan Africa: a prospective study at Yaounde Central Hospital, Cameroon. AIDS Research Therapy. 2009;6(1):21.
Cauldbeck MB, O’Connor C, O’Connor MB, Saunders JA, Rao B, Mallesh VG, et al. Adherence to anti-retroviral therapy among HIV patients in Bangalore, India. AIDS Research Therapy. 2009;6:7.
Waters L, Nelson M. Why do patients fail HIV therapy? International Journal of Clinical Practice. 2007;61(6):983-90.
Hansana, V, Sanchaisuriya P, Durham J, Sychareun, V, Chaleunvong K, Boonyaleepun S, Schelp FP. Adherence to antiretroviral therapy among people living with HIV: a cross-sectional survey to measure in Lao PDR. BMC Public Health. 2013;13(1):617.
